DanielIWoronowMD
Cardiology • Rockville, MDAdult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Medicine, Georgetown University School of Medicine
Are you Dr. Woronow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
12609 Celtic CT
Rockville, MD 20850Phone+1 301-367-3856
Summary
- Dr. Daniel Woronow, MD is a cardiologist in Rockville, Maryland. He is currently licensed to practice medicine in Maryland, Tennessee, and Florida. He is affiliated with Holy Cross Hospital, Adventist HealthCare Rehabilitation, and MedStar Washington Hospital Center.
Education & Training
Brown UniversityFellowship, Cardiovascular Disease, 1981 - 1983
University of MarylandResidency, Internal Medicine, 1978 - 1981
Johns Hopkins University School of MedicineClass of 1978
Certifications & Licensure
FL State Medical License 1993 - 2025
MD State Medical License 1979 - 2025
DC State Medical License 1983 - 2022
TN State Medical License 2013 - 2015
OK State Medical License 1987 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 2 citationsRegarding "Retrograde administration of ultrasound-guided endovenous microfoam chemical ablation for the treatment of superficial venous insufficiency".Daniel Woronow, Thao Tran, Amy Chen, Monica A. Muñoz, Cindy Kortepeter
Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2019-03-01 - 10 citationsArterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and ...Connie Cheng, Michelle Nadeau Nguyen, Afrouz Nayernama, S. Christopher Jones, Michael Brave
Vascular Medicine. 2021-04-12 - 7 citationsValsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen
BMJ Open. 2023-04-17
Press Mentions
FDA Data Link Diabetes Drug Class to Gallbladder DiseaseAugust 30th, 2022
Professional Memberships
- Member
